Medicus Pharma (MDCX) Change in Cash (2024 - 2025)
Medicus Pharma (MDCX) reported Change in Cash of $43127.0 for Q4 2025, up 103.78% on a YoY basis from $21163.8 in Q4 2024, and up 104.28% quarter-over-quarter from -$1.0 million in Q3 2025.
Medicus Pharma (MDCX) Change in Cash (2024 - 2025) Analysis & Trends
Medicus Pharma has reported Change in Cash for 2 years, with the latest figure at $43127.0 in Q4 2025.
- For the quarter ending Q4 2025, Change in Cash rose 103.78% year-over-year to $43127.0; the trailing twelve-month figure through Dec 2025 stood at $4.5 million (up 85.72% YoY), and the FY2025 full-year result was $4.5 million, up 85.72% from the prior year.
- Change in Cash for Q4 2025 stood at $43127.0, up from -$1.0 million in the prior quarter.
- The five-year high for Change in Cash was $7.9 million in Q2 2024, with the low at -$3.1 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 92,316,836.42 Bn | 92,316,831.46 Bn | 7.76 Bn | -71.45 Mn |
| 2 | Eli Lilly | 983.57 Bn | 978.29 Bn | 16.22 Bn | -1.99 Bn |
| 3 | Johnson & Johnson | 553.56 Bn | 531.50 Bn | 15.96 Bn | 1.98 Bn |
| 4 | AbbVie | 383.35 Bn | 374.00 Bn | 10.78 Bn | 4.16 Bn |
| 5 | Merck | 281.71 Bn | 276.06 Bn | 12.09 Bn | -9.29 Bn |
| 6 | Amgen | 182.20 Bn | 170.16 Bn | 5.87 Bn | 2.91 Bn |
| 7 | Gilead Sciences | 153.71 Bn | 145.98 Bn | 5.52 Bn | 65.00 Mn |
| 8 | Pfizer | 143.75 Bn | 130.98 Bn | -1.21 Bn | 563.00 Mn |
| 9 | Bristol Myers Squibb | 109.71 Bn | 99.25 Bn | 8.07 Bn | -635.00 Mn |
| 10 | Medicus Pharma | 7.87 Mn | 7.98 Mn | - | 43,127.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 43,127.00 |
| Sep 30, 2025 | -1.01 Mn |
| Jun 30, 2025 | 5.69 Mn |
| Mar 31, 2025 | -181,893.00 |
| Dec 31, 2024 | -1.14 Mn |
| Sep 30, 2024 | -3.10 Mn |
| Jun 30, 2024 | 7.87 Mn |
| Mar 31, 2024 | -1.18 Mn |